-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOXCEL THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES UPDATE ON LATE-STAGE CLINICAL PROGRAMS FOR AGITATION IN BIPOLAR, SCHIZOPHRENIA, AND ALZHEIMER’S DISEASE

Reuters·11/12/2025 12:00:04

Please log in to view news